Sumitomo Chemical and Sumitomo Pharmaceutical: Part II - CiRA, Dr. Yamanaka, and the undisclosed history of image duplication concerns
Updated: Aug 19
SUMMARY
Sumitomo Pharma targets 350 billion JPY in iPs revenue, including from Amchepry
The Center for iPS Cell Research & Application (CiRA) is SP’s research partner
CIRA is IPS cells supplier for the Amchepry trials, conducts the trials + research
CiRA is paid by Sumitomo Pharma, with a relationship since 2011.
Sumitomo Pharma is going all-in on CiRA while Takeda recently terminated its 10 year partnership with CiRA.
There are two well documented cases of fraud involving CiRa and its founder Shinya Yamanaka, in 2014 and 2018.
However, we have discovered 8 additional problematic cases, including 1 research paper where the Amchepry trial’s lead investigator is an author
Amchepry depends on the integrity of CiRA, but CiRa is suspect, unreliable.
For the full report:
When talking about any game, I feel that looking only at the final result is not enough. DM First Understanding the gameplay, rules, different situations, and the decisions players make gives a much better overall picture.
Thank you for this insightful analysis of the complexities surrounding Sumitomo's history. The notion of "tiny fishing 2" resonates with me; it highlights how small oversights can lead to significant implications in research integrity. Perhaps addressing these nuances more could enrich future discussions about accountability in biotech!
Mình cũng từng thấy e39app.com được nhắc trong vài cuộc thảo luận nên tò mò vào xem thử. Ấn tượng đầu tiên là giao diện khá gọn, các mục được sắp xếp tương đối dễ nhìn.
The discussion around research integrity and transparency is particularly important when scientific findings are connected to major medical developments. I found the points about data reliability and the need for careful review interesting, especially because trust is essential in research. Even when exploring unrelated areas online, from scientific reporting to pop-culture pieces like a hazel hook halloween costume, checking the source and context can make a big difference.
Short reports targeting major pharma partnerships often highlight how deeply financial valuations depend on institutional research integrity and transparent reporting. When multi-billion-yen commercial projections rely heavily on academic collaborations, allegations around data integrity create massive volatility and reputational risk for both enterprise sponsors and research institutes.
In high-stakes corporate shifts and complex business restructuring, having secure, modern IT infrastructure behind the scenes is essential for handling auditing, compliance, and operational data smoothly. When organizations navigate major corporate transitions or modernizing legacy infrastructure, leveraging structured cloud migration services ensures data integrity, compliance readiness, and uninterrupted system stability throughout the shift.
Fascinating breakdown of the intersection between short-seller scrutiny, biotech valuations, and institutional accountability.